These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33961136)

  • 1. Circulating anti-human leukocyte antigen IgM antibodies as a potential early predictor of allograft rejection and a negative clinical outcome after lung transplantation.
    Miyahara K; Miyoshi K; Kurosaki T; Otani S; Sugimoto S; Yamane M; Toyooka S
    Surg Today; 2022 Jan; 52(1):52-60. PubMed ID: 33961136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study.
    Brugière O; Thabut G; Krawice-Radanne I; Rizzo R; Dauriat G; Danel C; Suberbielle C; Mal H; Stern M; Schilte C; Pretolani M; Carosella ED; Rouas-Freiss N
    Am J Transplant; 2015 Feb; 15(2):461-71. PubMed ID: 25488753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.
    Lietz K; John R; Burke E; Schuster M; Rogers TB; Suciu-Foca N; Mancini D; Itescu S
    Circulation; 2005 Oct; 112(16):2468-76. PubMed ID: 16230499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the preoperative prognostic nutritional index score as a predictor of chronic lung allograft dysfunction after lung transplantation: a Japanese single-institution study.
    Kanou T; Minami M; Funaki S; Ose N; Fukui E; Kimura K; Shintani Y
    Surg Today; 2021 Dec; 51(12):1946-1952. PubMed ID: 33839934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of human leukocyte antigen mismatch on lung transplant outcome.
    Yamada Y; Langner T; Inci I; Benden C; Schuurmans M; Weder W; Jungraithmayr W
    Interact Cardiovasc Thorac Surg; 2018 May; 26(5):859-864. PubMed ID: 29300898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies.
    Yousem SA; Zeevi A
    Am J Surg Pathol; 2012 Jul; 36(7):987-92. PubMed ID: 22510758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
    George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
    J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant.
    Paul P; Pedini P; Lyonnet L; Di Cristofaro J; Loundou A; Pelardy M; Basire A; Dignat-George F; Chiaroni J; Thomas P; Reynaud-Gaubert M; Picard C
    Front Immunol; 2019; 10():1208. PubMed ID: 31249568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D; Bach C; Staudner C; Böger CA; Bergler T; Banas B; Spriewald BM
    Nephrol Dial Transplant; 2017 Apr; 32(4):730-737. PubMed ID: 28339671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fraction of sensitization among lung transplant recipients in a transplant center in Japan.
    Kumata S; Hirama T; Watanabe Y; Oishi H; Niikawa H; Akiba M; Tikkanen J; Okada Y
    BMC Pulm Med; 2020 Oct; 20(1):256. PubMed ID: 33008353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-G*01:04∼UTR3 Recipient Correlates With Lower Survival and Higher Frequency of Chronic Rejection After Lung Transplantation.
    Di Cristofaro J; Reynaud-Gaubert M; Carlini F; Roubertoux P; Loundou A; Basire A; Frassati C; Thomas P; Gomez C; Picard C
    Am J Transplant; 2015 Sep; 15(9):2413-20. PubMed ID: 25989360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of antidonor immunoglobulin M levels precedes acute lung transplant rejection.
    Miyoshi K; Sano Y; Yamane M; Toyooka S; Oto T; Miyoshi S
    Ann Thorac Surg; 2011 Oct; 92(4):1233-8. PubMed ID: 21855852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients.
    Stastny P; Ring S; Lu C; Arenas J; Han M; Lavingia B
    Hum Immunol; 2009 Aug; 70(8):600-4. PubMed ID: 19375468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation.
    Smith JD; Ibrahim MW; Newell H; Danskine AJ; Soresi S; Burke MM; Rose ML; Carby M
    J Heart Lung Transplant; 2014 Oct; 33(10):1074-82. PubMed ID: 24954882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of donor-specific antibodies on graft outcome in pediatric renal transplantation from deceased donors.
    Piątosa B; Kwiatkowska A; Rubik J; Jarmużek W; Kluge P; Grenda R
    Ann Transplant; 2011; 16(4):32-9. PubMed ID: 22210419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
    Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
    Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of pretransplant class I and II non-donor-specific anti-HLA immunization on immunologic outcome and graft survival in kidney transplant recipients.
    Staeck A; Khadzhynov D; Kleinsteuber A; Lehner L; Duerr M; Budde K; Lachmann N; Halleck F; Staeck O
    Transpl Immunol; 2020 Dec; 63():101333. PubMed ID: 32919027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel biomarker combination predicts long-term allograft outcome.
    Cail J; Huang W; Terasaki PI; Everly MJ; Briley KP; Haisch CE; Bolin P; Kendrick WT; Kendrick SA; Morgan C; Harland RC; Rebellato LM
    Clin Transpl; 2013; ():319-24. PubMed ID: 25095524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reevaluation of the role of IgM Non-HLA antibodies in cardiac transplantation.
    Smith JD; Hamour IM; Burke MM; Mahesh B; Stanford RE; Haj-Yahia S; Robinson DR; Kaul P; Yacoub MH; Banner NR; Rose ML
    Transplantation; 2009 Mar; 87(6):864-71. PubMed ID: 19300190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.